Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

GRANISETRON-AFT SOLUTION FOR INJECTION 1MG/ML

Approval Number

SIN14612P

Drug Name

GRANISETRON-AFT SOLUTION FOR INJECTION 1MG/ML

Product Name

GRANISETRON-AFT SOLUTION FOR INJECTION 1MG/ML

Approval Date

September 11, 2014

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

Registrant

APEX PHARMA MARKETING PTE. LTD.

Licence Holder

APEX PHARMA MARKETING PTE. LTD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

INJECTION, SOLUTION

Route of Administration

INTRAVENOUS, INTRAMUSCULAR

Medical Information

ATC Code

A04AA02

ATC Item Name

granisetron

Manufacturer Information

Pharmaceutical Manufacturer

APEX PHARMA MARKETING PTE. LTD.

Manufacturers

QILU PHARMACEUTICAL CO., LTD

Active Ingredients

Ingredient Name

GRANISETRON HYDROCHLORIDE 1.12 mg EQV GRANISETRON

Strength

1 mg/ml

Drug MonographGranisetron

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy